1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals, Inc.

VRPX
Virpax Pharmaceuticals, Inc.US flagOther OTC
0.00
USD
-0.01
- -
497.00Market Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
3
3
4
12
22
17
12
+ Selling, General & Admin
1
3
3
7
11
12
6
+ Research & Development
1
1
1
5
11
5
6
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-3
-3
-4
-12
-22
-17
-12
- Non-Operating (Income) Loss
- -
- -
- -
- -
- -
-2
- -
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
-2
- -
Pretax Income
-3
-3
-4
-12
-22
-15
-12
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-3
-3
-4
-12
-22
-15
-12
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-3
-3
-4
-12
-22
-15
-12
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-3
-3
-4
-12
-22
-15
-12
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-3
-3
-4
-12
-22
-15
-12
EBIT
-3
-3
-4
-12
-22
-17
-12
EBITDA
-3
-3
-4
-12
-22
-17
-12
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
EBITA
-3
-3
-4
-12
-22
-17
-12
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-133.52
-167.16
-240.62
-451.39
-462.15
-324.22
- -
Basic EPS from Cont Ops
-133.52
-167.16
-240.62
-451.39
-462.15
-324.22
- -
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
Diluted EPS, GAAP
-133.52
-167.16
-240.62
-451.39
-462.15
-324.22
- -
Diluted EPS from Cont Ops
-133.52
-167.16
-240.62
-451.39
-462.15
-324.22
- -

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Total Current Assets
- -
- -
- -
40
20
10
2
+ Cash, Cash Equivalents & STI
- -
- -
- -
37
19
9
2
+ Cash & Cash Equivalents
- -
- -
- -
37
19
9
2
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
3
1
- -
- -
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
Total Assets
- -
- -
- -
40
20
10
2
+ Payables & Accruals
1
1
2
2
1
2
2
+ Accounts Payable
- -
- -
- -
- -
- -
- -
- -
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
2
2
1
2
2
+ ST Debt
- -
1
1
- -
- -
- -
- -
+ ST Borrowings
- -
1
1
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
1
1
- -
2
6
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
1
- -
2
6
- -
Total Current Liabilities
1
3
4
2
3
8
2
+ LT Debt
- -
- -
1
- -
- -
- -
- -
+ LT Borrowings
- -
- -
1
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
1
- -
- -
- -
- -
Total Liabilities
1
3
5
2
3
8
2
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
2
4
6
60
61
61
71
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
2
4
6
60
61
61
71
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-3
-6
-11
-23
-44
-60
-72
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-1
-3
-4
37
17
2
-1
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
-1
-3
-4
37
17
2
-1
Total Liabilities & Equity
- -
- -
- -
40
20
10
2
Shares Outstanding
- -
- -
- -
- -
- -
- -
1
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
Net Debt
- -
1
2
-37
-19
-9
-2
Net Debt to Equity
-37.87
-44.76
-35.83
-98.29
-114.57
-472.6
165.59
Tangible Common Equity Ratio
-1,939.39
-5,848.32
-905.9
94.72
84.27
20.09
-58.74
Current Ratio
0.05
0.02
0.02
18.96
6.36
1.25
0.63
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
+ Net Income
-3
-3
-4
-12
-22
-15
-12
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
1
2
1
1
1
- -
+ Stock-Based Compensation
- -
1
1
1
1
1
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
1
- -
- -
- -
- -
- -
+ Chg in Non-Cash Work Cap
- -
1
1
-3
3
5
-5
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
-3
2
- -
- -
+ Inc (Dec) in Accts Payable
- -
1
1
-1
-1
1
1
+ Inc (Dec) in Other
- -
- -
- -
- -
2
4
-6
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-2
-1
-1
-15
-18
-10
-17
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
1
1
1
58
- -
- -
6
+ Increase in Capital Stock
1
1
1
58
- -
- -
6
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
1
- -
- -
-3
- -
- -
- -
+ Cash From Debt
1
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
-3
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
-4
- -
- -
3
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
2
1
1
51
- -
- -
9
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
- -
37
-18
-10
-8
EBITDA
-3
-3
-4
-12
-22
-17
-12
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-2
-1
-1
-15
-18
-10
-17
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-1
-1
-18
-18
-10
-17
Free Cash Flow per Basic Share
-90.98
-57.22
-76.79
-544.48
-380.95
-210.33
- -
Price/Free Cash Flow
- -
- -
- -
-1.57
-0.41
-0.38
- -
Cash Flow to Net Income
0.68
0.34
0.32
1.21
0.82
0.65
1.38
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -